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Metabotropic Regulation of RhoA/Rho-Associated Kinase by
L-type Ca2 Channels
New Mechanism for Depolarization-Evoked Mammalian
Arterial Contraction
Miguel Ferna´ndez-Tenorio, Cristina Porras-Gonza´lez, Antonio Castellano, Alberto del Valle-Rodríguez,
Jose´ Lo´pez-Barneo, Juan Uren˜a
Background: Sustained vascular smooth muscle contraction is mediated by extracellular Ca2 influx through L-type
voltage-gated Ca2 channels (VGCC) and RhoA/Rho-associated kinase (ROCK)-dependent Ca2 sensitization of the
contractile machinery. VGCC activation can also trigger an ion-independent metabotropic pathway that involves
G-protein/phospholipase C activation, inositol 1,4,5-trisphosphate synthesis, and Ca2 release from the sarcoplasmic
reticulum (calcium channel-induced Ca2 release). We have studied the functional role of calcium channel-induced
Ca2 release and the inter-relations between Ca2 channel and RhoA/ROCK activation.
Methods and Results: We have used normal and genetically modified animals to study single myocyte electrophys-
iology and fluorimetry as well as cytosolic Ca2 and diameter in intact arteries. These analyses were complemented
with measurement of tension and RhoA activity in normal and reversibly permeabilized arterial rings. We have found
that, unexpectedly, L-type Ca2 channel activation and subsequent metabotropic Ca2 release from sarcoplasmic
reticulum participate in depolarization-evoked RhoA/ROCK activity and sustained arterial contraction. We show that
these phenomena do not depend on the change in the membrane potential itself, or the mere release of Ca2 from the
sarcoplasmic reticulum, but they require the simultaneous activation of VGCC and the downstream metabotropic
pathway with concomitant Ca2 release. During protracted depolarizations, refilling of the stores by a residual
extracellular Ca2 influx through VGCC helps maintaining RhoA activity and sustained arterial contraction.
Conclusions: These findings reveal that calcium channel-induced Ca2 release has a major role in tonic vascular
smooth muscle contractility because it links membrane depolarization and Ca2 channel activation with metabotropic
Ca2 release and sensitization (RhoA/ROCK stimulation). (Circ Res. 2011;108:1348-1357.)
Key Words: calcium channels  sarcoplasmic reticulum  vascular smooth muscle  vasoconstriction
Cardiovascular diseases secondary to alterations in thearterial diameter constitute an important cause of mor-
bidity and mortality in humans; however, the mechanisms
that determine vascular smooth muscle (VSM) contractility
are not fully understood. Myocyte contraction is triggered by
the increase of cytosolic Ca2 concentration ([Ca2]i) because
of Ca2 influx through ion channels in the plasmalemma, Ca2
release from the sarcoplasmic reticulum (SR), or both. Besides
exerting direct control of myosin light chain phosphorylation,
cytosolic Ca2 also influences VSM contraction through en-
hancement of the sensitivity of the contractile apparatus, a
process called Ca2 sensitization that is mediated by the small
monomeric G-protein RhoA and its target Rho-associated kinase
(ROCK). The RhoA/ROCK pathway, presumed to be involved
in the pathogenesis of major vascular disorders,1,2 is turned on
by excitatory agonists through G-protein-coupled receptor stim-
ulation,3–5 and it also seems to be activated by membrane
depolarization.6–10 Nonetheless, the relationships between mem-
brane voltage changes, cellular Ca2 regulation, and RhoA
activation remain obscure. We have hypothesized that activation
of voltage-dependent Ca2 channels and RhoA could share
some common mechanisms.
Ca2 influx through voltage-gated L-type Ca2 channels
(VGCC) is a major event in VSM excitation– contraction
coupling. Depolarization is also known to induce Ca2
release from the SR independently of extracellular Ca2
influx (depolarization-induced Ca2 release) by means of a
metabotropic pathway that involves G-protein/phospho-
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lipase C (PLC) activation and inositol 1,4,5-trisphosphate
(InsP3) synthesis.11–14Although other membrane proteins in the
receptor/G-protein/PLC cascade have been proposed to be volt-
age-sensitive,15–17 it has been shown that L-type Ca2 channels
are necessary for depolarization-induced Ca2 release in vascu-
lar14,18–20 and skeletal21 muscle. Therefore, plasmalemmal Ca2
channels in VSM have been suggested to act as voltage sensors
that mediate ion-independent coupling between membrane de-
polarization and SR Ca2 release (Ca2 channel-induced Ca2
release [CCICR]).14,20 The precise physiological role of CCICR
and its inter-relations with the RhoA/ROCK pathway are as yet
unexplored. Herein, we show that, unexpectedly, CCICR is
necessary for sustained VSM contraction and that maintenance
of arterial tone requires Ca2 channel-dependent RhoA activa-
tion. Our data suggest that sarcolemmal VGCC not only mediate
the Ca2 influx that triggers contraction but also metabotropi-
cally regulate SR Ca2 release and RhoA activation to sensitize
the contractile machinery. These novel findings suggest that
Ca2 channels have a role in the regulation of VSM tonus much
broader than previously thought and provide a comprehensive
view of myocyte contractility. This work helps identify mecha-
nisms responsible for hypertension as well as arterial (eg,
coronary or cerebral) vasospasms.
Subjects and Methods
Animal Models
Rats and mice were anesthetized with ketamine (80 mg/kg intramuscu-
lar). Rabbits were anesthetized with sodium pentobarbital (75 mg/kg
intravenous). Cav1.2 knockout animals were generated at the Institut fu¨r
Pharmakologie und Toxikologie, Mu¨nchen, Germany.22,20 All of the
experimental procedures were approved by the Institutional Animal
Care and Use Committee and were conducted in conformity with
institutional guidelines.
Cytosolic Ca2 Measurements and Electrophysiological
Recordings in Isolated Myocytes
Cytosolic [Ca2] and patch clamp recordings from dispersed myo-
cytes were performed as previously described.14
Confocal Microscopy and Immunocytochemistry
Immunocytochemical studies were performed on fixed cells follow-
ing standard protocols. For details, see Methods in the online Data
Supplements.
Measurement of Contractility in Arterial Rings and RhoA
Activation Assay
Contractility of arterial rings was studied as previously described.18
RhoA activity was determined from quickly frozen arterial rings
(immersed in liquid nitrogen) using the colorimetric G-LISA RhoA
activation assay biochemistry kit (Cytoskeleton, Denver, CO). For
details, see Methods in the online Data Supplements.
Simultaneous Measurements of Fluorescence
and Contractility
Basilar arteries (12–14 mm) were incubated in Hank’s containing
Fura 2 AM 1.4 mol/L for 1 hour at room temperature. Experiments
were performed as previously described.19
Reversible Permeabilization
Reversible permeabilization was achieved by a modification of
previous methods.23,24 For details and solutions, see Methods in the
Online Data Supplement at http://circres.ahajournals.org.
Statistical Analysis
Data are expressed as meanstandard error and the statistical signifi-
cance was estimated using the Student t test. Values of P0.05 were
considered significant.
Results
Sustained Depolarization-Evoked Vascular
Myocyte Contraction Requires Metabotropic Ca2
Release From the SR
To investigate the functional role of metabotropic Ca2 release
from the SR evoked by VGCC activation (CCICR),14,20,25 basilar
arterial rings were stimulated by exposure to an external solution
containing 70 mmol/L K, which depolarizes isolated current-
clamped arterial myocytes.14 The high K solution shifted the
membrane potential of basilar VSM cells from 50 mV to
20 mV. Depolarization with 70K triggered an isometric
contraction that showed an initial fast and transient (phasic)
component, followed by a slowly increasing (tonic) component,
which was generally maintained until the end of the stimulus
(Figure 1A; Online Figure IA and B). These phasic and tonic
components were also observed in contractions evoked by
application of ATP, a vasoactive agent that induces activation of
VGCC26,18 (Figure 1B). Treatment of the arteries with cyclopia-
zonic acid (CPA), an SR Ca2 ATPase inhibitor that depletes
Ca2 stores without effects on VGCC (online Figure IIA and B),
selectively reduced the tonic component of contractions evoked
by either high K or ATP (Figure 1A and 1B). Similar results
(decrease of the sustained phase of arterial contraction) were
observed with two other drugs (thapsigargin and ryanodine) that
also reduce Ca2 storage in SR (Online Figure IIC and IID).
These data indicated that the sustained component of
depolarization-evoked VSM contraction depends on Ca2 re-
lease from intracellular stores, possibly as a consequence of
CCICR. CCICR is inhibited by organic VGCC antagonists;14,18
hence, we tested the effect of nifedipine on depolarization-
evoked contractions. Nifedipine was more potent to inhibit the
tonic than the phasic components of contractions. Nifedipine (10
nmol/L) produced a marked reduction of the high K-evoked or
ATP-evoked tonic contraction leaving intact the phasic period.
At higher concentrations of nifedipine (100 nmol/L), the two
phases of contraction were abolished (Figure 1C and 1D; Online
Figure IIE and IIF). These results suggest that VSM cell
contraction elicited by cell depolarization depends on both
ionotropic (Ca2 entry) and metabotropic (CCICR) actions of
plasmalemmal Ca2 channels.
To test whether depolarization-evoked sustained VSM con-
traction does involve metabotropically induced Ca2 release,
Non-standard Abbreviations and Acronyms
CCICR calcium channel-induced Ca2 release
CPA cyclopiazonic acid
FPL FPL64176
InsP3 inositol 1,4,5-trisphosphate
PLC phospholipase C
ROCK Rho-associated kinase
SR sarcoplasmic reticulum
VGCC L-type voltage-gated Ca2 channels
VSM vascular smooth muscle
Ferna´ndez-Tenorio et al CCICR and RhoA/ROCK in Vascular Smooth Muscle 1349
 by guest on March 4, 2013http://circres.ahajournals.org/Downloaded from 
arterial rings were exposed to U73122, an inhibitor of PLC.14
This treatment left unaffected the phasic component of the
70K-evoked contraction but markedly reduced the tonic com-
ponent. U73343, a structurally closely related compound that
does not inhibit PLC, did not significantly affect VSM contrac-
tility (Figure 2A). Similar results were obtained in basilar arterial
rings contracted with ATP and treated with U73122 (Figure 2B).
The effect of U73122 was mediated by changes in [Ca2]i,
because in isolated myocytes U73122 decreased the sustained
phase of the 70K-induced Ca2 signal, with no significant effect
Figure 1. Effect of cyclopiazonic acid
(CPA) and nifedipine (Nif) on contrac-
tion in rat basilar arterial rings. A, Iso-
metric contraction induced by
70 mmol/L external K solution (70K)
with a phasic component of 7.130.23
mN, reached at 15 seconds, and a
tonic component with a tension of
7.880.3 mN (determined at 6 minutes,
n45). Application for 30 to 40 minutes
of 10 mol/L CPA selectively reduced
the maintained phase of the 70K-evoked
contraction (22%7.3%; n6; P0.05),
leaving the phasic component unaffected
(1%3.5% potentiation; n6; P0.05).
B, Representative traces of isometric
force developed by arterial rings in
response to ATP (25 mol/L). The fast
transient component was not signifi-
cantly affected in arterial rings treated
with 10 mol/L CPA for 20 minutes. The
slow component, measured 30 seconds
after the peak, was markedly reduced
(66%17.6%; n6; P0.05). C, Nifedi-
pine (10 nmol/L) selectively inhibited the
tonic component (57.9%5.94%; n11;
P0.01), leaving the phasic component
unaffected (4.26%2.6% inhibition;
n11; P0.05). Nifedipine (100 nmol/L)
markedly inhibited both phasic and
tonic components of contraction
(67.52%8.45%; n7; P0.01; and 91.55%2.16%; n7; P0.01, respectively). D, Nifedipine (10 nmol/L) selectively inhibited the
slow component of the ATP-evoked contraction measured 2 minutes after the peak (3.7% for the fast component; n8; P0.05; 69%
for the slow component; n8; P0.01). Nifedipine (100 nmol/L) markedly reduced both components of the ATP-elicited contraction
(77% fast component; n8; P0.01; 86% slow component; n8; P0.01).
Figure 2. Participation of phospholipase C and
G-protein in the tonic phase of depolarization-
evoked contractions in rat basilar arteries. A,
Treatment of arterial rings for 20 to 40 minutes
with U73122 (1 mol/L) left the phasic component
of the 70K-evoked contraction unaffected
(1%15% inhibition; n6; P0.05) and signifi-
cantly reduced the amplitude of the tonic compo-
nent (38%12% inhibition; n6; P0.01). U73343
(1 mol/L) did not significantly affect the phasic or
tonic components (1.2%1.1% inhibition; n8;
P0.05; 3.9%2.4% potentiation; n8; P0.05,
respectively, measurement at 20 minutes). B,
Bathing arterial rings with U73122 (1 mol/L) for
10 minutes reduced the tonic component of the
ATP-induced contraction measured 30 seconds
after the peak (52% inhibition; n6; P0.01),
whereas the phasic component was not signifi-
cantly affected (17% inhibition; n6; P0.05). C
and D, Effect of GDPS (10 mmol/L) on contrac-
tions induced by depolarization (70K) and caffeine
(10 mmol/L) in reversibly permeabilized arteries.
Values are presented as meanSEM *P0.05.
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on the transient component (Online Figure IIIA through IIID).
Further support for the notion that the G-protein/PLC pathway
participates in depolarization-induced tonic contractions came
from experiments on intact arteries in which myocytes had been
reversibly permeabilized in the presence of GDPS to inhibit
G-protein activation.14,23,24 In these arteries, the tonic component
of the 70K-evoked VSM contraction was also selectively re-
duced, whereas the phasic component of contraction and the
mechanical signal induced by caffeine (a drug that directly elicits
Ca2 release from the SR) were unaltered (Figure 2C and 2D).
Together, these results further supported the notion that stimu-
lation of the G-protein/PLC cascade subsequent to membrane
depolarization and Ca2 channel activation leads to the SR Ca2
release necessary for maintained VSM contraction.
Sustained Depolarization-Evoked Contraction Requires
G-Protein-Dependent and InsP3-Dependent
RhoA/ROCK Activation
In VSM, a Ca2 sensitization mechanism mediated by the
RhoA/ROCK pathway seems to participate in the depolarization-
evoked contraction; however, the underlying mechanisms are
not well-known.6–10 We tested in immunostained isolated
myocytes the redistribution of activated RhoA and its dis-
placement toward the plasma membrane in response to high
K-induced depolarization (Figure 3A through 3C).9,27 Be-
cause ROCK is a RhoA downstream effector, we studied in
intact pressurized arteries the effect of Y27632, a ROCK
inhibitor,1 on the cytosolic Ca2 and mechanical responses to
high K. ROCK blockade did not modify the Ca2 signal
elicited by depolarization but selectively inhibited the tonic
component of the contraction (Figure 3D). Qualitatively similar
results (inhibition of the tonic phase of contraction) were
obtained in arterial rings treated with HA1077, another ROCK
inhibitor structurally unrelated to Y276321 (Online Figure IIIE
and IIIF). These experimental observations further suggested
that the depolarization-evoked sustained phase of contraction
requires, at least in part, RhoA/ROCK activation.
To show the parallel metabotropic regulation of tonic
contraction and RhoA activation, we performed experiments
in reversibly permeabilized arteries (Figure 2C and 2D) that
were frozen at the end of the depolarization pulse (10
minutes after exposure to high K) to directly measure
RhoA activity. Application of GDPS and heparin (inhib-
itors of G-protein activation and InsP3 receptors, respec-
tively) selectively reduced the tonic component of the
70K-evoked contractions and also decreased RhoA activity
induced by depolarization (Figure 4; Online Figure IC).
These observations supported the view that metabotropic
Ca2 release from the SR elicited by membrane depolar-
ization maintains tonic contractions through activation of
the RhoA/ROCK pathway.
Figure 3. Cytosolic distribution of acti-
vated RhoA in isolated myocytes and
effect of the Rho-associated kinase
(ROCK) inhibitor Y27632 on 70K-
induced contraction in rat basilar
artery. A and B, Confocal immunofluo-
rescent images of RhoA distribution
(RhoA, green; cell nucleus, red) in a sin-
gle basilar smooth muscle cell at rest (A)
and after stimulation with 70K (B). Scale
bars7 m. C, Averaged peripheral:cy-
tosolic (Fm/Fc) RhoA ratios for two cen-
tral z-sections in control and 70K-
induced depolarization (n12). D, Effect
of the ROCK inhibitor Y27632
(10 mol/L) on cytoplasmic Ca2 and
diameter (36.6%9.27% inhibition of
tonic component; n4; P0.05) in an
intact artery depolarized with 70K. Val-
ues are presented as meanSEM
*P0.05.
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Essential Role of L-type Ca2 Channel Activation and
Ca2Channel-Induced Ca2 Release in Depolarization-Evoked
RhoA Activation and Sustained Myocyte Contraction
Because depolarization-evoked tonic myocyte contraction is
paralleled by metabotropic RhoA/ROCK activation, we tested to
see whether blockade of tonic contractility with nifedipine
(Figure 1C and 1D) also altered RhoA activity. As expected,
70K-induced contractions and RhoA activation in arterial
rings were fully prevented by nifedipine (Figure 5A, top and
bottom), thus suggesting that Ca2 channel activation is
required to increase RhoA activity. The critical role of VGCC
activation (independently of membrane depolarization) in
RhoA regulation was further supported by two sets of
experiments. First, the application of FPL64176 (FPL), a
selective L-type Ca2 channel agonist with minor effects on
the resting membrane potential,14,18 induced a contraction that
was fully blocked by nifedipine (Figure 5B and 5C, top
panels; Online Figure ID and IE). RhoA activity, which
increased by FPL in parallel with the mechanical response,
was also almost abolished by nifedipine application (Figure
5B and 5C, bottom panels). Second, in a conditional Cav1.2
(L-type) Ca2 channel knockout mice model,22,20 contractile
responses to 70K and FPL were greatly reduced in parallel
with inhibition of RhoA activity (Figure 6). In these geneti-
cally modified animals, contractions induced by application
of either phenylephrine or caffeine (because of Ca2 release
from InsP3 or ryanodine-sensitive stores, respectively)28,29
were unaffected, thus indicating that VGCC deficiency did
not alter other physiological features of the VSM cells. The
RhoA/ROCK pathway was maintained functional in Cav1.2
null myocytes because it was activated by phenylephrine with
similar potency as in control cells (Figure 6D). Moreover, the
sustained contraction evoked by phenylephrine was blocked
by pharmacological ROCK inhibition (Online Figure IV).
Figure 4. Participation of
G-proteins and inositol 1,4,
5-trisphosphate (InsP3) recep-
tors in the sustained compo-
nent of the depolarization-
induced contraction and
RhoA activation in rabbit fem-
oral arteries. A, Effect of
GDPS (10 mmol/L) on contrac-
tion induced by depolarization
(70K) and caffeine (10 mmol/L)
in reversibly permeabilized arter-
ies. B, Quantitative summary of
relative isometric force devel-
oped in response to the differ-
ent stimuli, 70K or caffeine
(n11). C, Effect of GDPS on
RhoA activation (relative to rest-
ing condition in the absence of
any stimulus) during 70K-
induced depolarization (n5). D,
Effect of heparin (10 mg/mL) on
contractions induced by 70K
and caffeine (10 mmol/L) in reversibly permeabilized arteries. E, Quantitative summary of isometric force developed in response to the differ-
ent stimulus (70K, n17; caffeine, n14). F, Effect of heparin on RhoA activation during the 70K-induced depolarization (relative to resting
conditions). The vertical arrows indicate the time at which 70K-evoked force was measured and arterial rings were frozen (F) for posterior
measurement of RhoA activity (10 minutes after 70K application). Values are presented as meanSEM. *P0.05, **P0.01.
Figure 5. Effect of nifedipine on 70K-
induced and FPL64176 (FPL)-induced
contraction and RhoA activation in
rabbit basilar artery. A, Statistical
analysis of isometric contraction (top)
and RhoA activity (bottom) measured
10 minutes after stimulation induced
by 70K in the presence or absence of
nifedipine (1 mol/L, n3). RhoA activ-
ity is normalized to basal condition
(control). B, Time-dependent changes
in contraction (top) and RhoA activa-
tion (bottom) in basilar arterial rings
stimulated with FPL (0.5 mol/L). The
vertical arrows indicate the time at
which arterial rings were frozen (F) for
posterior measurement of RhoA activ-
ity (2 minutes, n3; 10 minutes, n10;
30 minutes, n3). C, Statistical analy-
sis of isometric contraction (top) and
RhoA activity (bottom, measured at 10
minutes after stimulation) induced by
FPL (0.5 mol/L) in the presence (n32) or absence (n3) of 1 mol/L nifedipine. Values are presented as meanSEM. **P0.01.
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To distinguish between the effects of Ca2 channel acti-
vation (and the downstream metabotropic pathway) and Ca2
entry/release on RhoA activation, we performed experiments
in arteries bathed in Ca-free solutions (0Ca plus 1 mmol/L
EGTA; estimated [Ca2]I 100 nmol/L) to prevent any
transmembrane Ca2 influx. In these conditions, caffeine
induced a transient Ca2 release signal that triggered arterial
contraction (Online Figure VA). These effects of caffeine
decreased progressively as the SR stores were depleted of
Ca2 (Figure 7A). RhoA activity measured 10 minutes after
caffeine application was similar to control values (Figure 7B
and 7C), thus indicating that caffeine-induced Ca2 release
and contraction occur without involvement of the RhoA/
ROCK pathway. Pharmacological inhibition of ROCK did
not produce any effect on the mechanical responses to
caffeine (Online Figure VB). Application of a membrane-
permeant InsP3 derivative also failed to induce contraction
and RhoA activation in arterial rings (Online Figure VI).
Therefore, SR Ca2 release per se (bypassing Ca2 channel-
induced metabotropic activation) does not seem to be suffi-
cient to activate RhoA. In contrast to caffeine, FPL (that also
induced a transient Ca2 signal and arterial contraction;
online Figure VC) elicited a marked RhoA activation that
decreased with time as the SR was depleted of Ca2 (Figure
7D). On exposure to FPL, RhoA activity increased to a
maximal value that started to decrease 10 minutes after
treatment (Figure 7E and 7F). These findings contrast with
the results shown before in the presence of extracellular
Ca2, a condition in which FPL induced sustained contrac-
tion and RhoA activation (Figure 5B). In accord with these
observations, FPL-induced contraction was inhibited by phar-
macological blockade of ROCK (Online Figure VD).
It is known that phosphorylation of myosin light chain in
KCl-stimulated myocytes is highly sensitive to [Ca2]i;8
hence, we sought to determine whether changes in extracel-
lular [Ca2] can modify RhoA activation. Experiments were
performed to compare the data described before in arteries
bathed in 0Ca plus EGTA solutions (estimated [Ca2] 100
nmol/L) with preparations exposed to 0Ca solutions without
EGTA added (estimated [Ca2] 7 mol/L) for more than
60 minutes. In this last solution, both caffeine-evoked con-
traction and FPL-induced RhoA activation remained similar
to the values observed in control conditions, before applica-
tion of any stimulus (Figures 8A, 8B, 7A, and 7D). FPL
elicited a sustained contraction paralleled by an increase in
RhoA activity that, after reaching a maximal value, remained
almost constant or declined slowly during treatment (Figures
8C, 8D, 7E, and 7F). FPL-induced sustained contraction was
decreased by pharmacological ROCK inhibition, whereas the
cytosolic Ca2 signal was not affected (Online Figure VE).
Interestingly, the level of FPL-evoked RhoA activation, after
10 minutes of treatment, was not significantly different in
arterial rings bathed in either 7 mol/L (136%8%; n8;
Figure 8D) or 2.5 mmol/L (143%6%; n10; Figure 5B)
Ca2 (P0.18), thus suggesting that VSM cells have a highly
effective Ca2 uptake system that can maintain refilling the
intracellular stores even when extracellular [Ca2] is reduced
to mol/L levels.
Altogether, these data suggest that depolarization-evoked
sustained RhoA activation and myocyte contraction do not
depend on the change in the membrane potential per se or the
simple release of Ca2 from the SR, but they require the
simultaneous activation of VGCC and the downstream stim-
ulation of a metabotropic pathway leading to InsP3 synthesis
and Ca2 release. Therefore, CCICR has a major role in tonic
VSM contractility because it links Ca2 channel activation
with metabotropic Ca2 release and sensitization (RhoA/
ROCK stimulation).
Discussion
In this article, we describe that besides their classical ionotropic
role responsible for Ca2 entry and the Ca2/calmodulin-
dependent activation of myosin light chain kinase, L-type Ca2
channels have other unexpected functions required for mainte-
nance of depolarization-evoked contraction in VSM cells. We
show that L-type Ca2 channel activation constitutes the key
Figure 6. Genetic ablation of L-type
Ca2 channels reduces depolarization
or FPL64176 (FPL)-evoked contraction
and RhoA activity in mouse aorta. Rep-
resentative traces of contractions evoked
by 70K (A) or FPL (B) in Cav1.2 wild-type
and Cav1.2-deficient mice. C, Quantitative
summary of isometric forces generated in
arterial rings in response to either 70K
(n16), FPL (5 mol/L, n10), phenyleph-
rine (1 mol/L, n12), and caffeine
(10 mmol/L, n28). Note that caffeine-
evoked and phenylephrine-evoked con-
tractions were not reduced in Cav1.2/
mice. D, Quantitative summary of RhoA
activity (normalized to resting condition)
generated in arterial rings in response to
either 70K (n3), FPL (5 mol/L, n3),
phenylephrine (1 mol/L, n3) and caf-
feine (10 mmol/L, n3). Note that RhoA
activity induced by phenylephrine was not
reduced in Cav1.2/ mice. Values are
presented as meanSEM. *P0.05,
**P0.01.
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event that triggers depolarization-dependent metabotropic Ca2
release from SR and smooth muscle sensitization through
activation of the RhoA/ROCK pathway. It had been described
before that in the absence of extracellular Ca2 influx, Ca2
channels of VSM cells act as voltage sensors that couple
membrane depolarization to InsP3 synthesis and Ca2 release
from SR (CCICR).14,25,20 We now show that in normal
conditions, CCICR mediates Ca2 release and sensitization
of the contractile apparatus necessary to generate sustained
VSM contractions.
Maintenance of Depolarization-Evoked Vascular Myocyte
Contraction Requires Functional Ca2 Channels and
Metabotropic Ca2 Release From the SR
In agreement with previous studies on other arteries,7,9 high
K-evoked contraction in basilar arterial rings exhibited a
time course characterized by an early transient phase fol-
lowed by a tonic sustained component. Transient and sus-
tained phases in vascular myocyte contraction were also
observed after application of agonists that activate membrane
VGCC.18 In this article, we provide strong evidence indicat-
ing that, besides transmembrane Ca2 influx, the sustained
phase of contraction also depends on Ca2 release from
internal stores. Therefore, CCICR, a mechanism described in
arteries bathed without external Ca2,14 seems to have a
major functional role in arterial contraction under normal
conditions. Exposure to high KCl is often used as a tool to
bypass G-protein–coupled receptor stimulation and activate
smooth muscle by changing the K equilibrium potential and
clamping membrane potential above resting level.10 How-
ever, it is well-established that in several cell types (including
VSM cells) membrane depolarization can induce direct acti-
vation of the G-protein-PLC cascade, leading to InsP3 syn-
thesis and Ca2 release. In vascular14,25,20 as well as in
skeletal muscle cells,21 a great deal of experimental evidence
exists supporting the view that VGCC are the voltage sensors
linking membrane depolarization to G-protein activation,
InsP3 synthesis, and Ca2 release. In bronchial smooth
muscle17 and megakaryocytes lacking VGCC,16 other mem-
brane proteins have been proposed to also have intrinsic
voltage sensitivity.16
In the present set of experiments, the role of CCICR on VSM
contraction, studied before in isolated myocytes, has been
investigated in arterial rings and reversibly “permeabilized”
arteries.23,24 These last preparations better-represent the in
vivo physiological conditions yet permit pharmacological
modifications of the extracellular and intracellular media. The
data show that sustained depolarization-evoked vascular con-
traction depends on G-protein/PLC/InsP3-mediated Ca2 re-
lease from the SR, a metabotropic pathway triggered by
VGCC activation. We find particularly conclusive the exper-
iments performed using the conditional L-type Ca2 channel
knockout mouse, in which we have recently shown the strict
dependence of depolarization-evoked Ca2 release on the
maintenance of functional Ca2 channels.20 In this animal
model, protracted VSM contraction induced by either mem-
brane depolarization (exposure to high K) or pharmacolog-
ical Ca2 channel activation (application of FPL) was re-
duced in parallel with the decrease of channel expression.
However, contractions induced by either caffeine, which
directly activates Ca2 release from stores,29,30 or phenyleph-
rine, which activates the G-protein/PLC cascade and
ROCK,28 were unaltered. Therefore, it seems that VGCC
have two different roles in the contractile response to depo-
larization. At first instance, membrane depolarization causes
massive Ca2 entry, myosin light chain kinase activation, and
a phasic contraction.31 During maintained depolarization,
channels undergo a conformational change (switching be-
tween inactive and open states) that triggers the metabotropic
cascade, resulting in Ca2 release from SR and tonic con-
traction. Ca2 channel inactivation and the displacement of
the membrane potential toward the Ca2 equilibrium poten-
tial drastically reduce transmembrane Ca2 influx. However,
a small steady-state Ca2 channel activity and Ca2 current
have been described in sustained depolarized myocytes.32,33
Figure 7. Ca2-dependence of the FPL64176 (FPL)-evoked
contraction in rabbit basilar artery. A, Statistical analysis of
the effect of 10 mmol/L caffeine on isometric force at different
times during depletion of intracellular calcium stores (n3). Caf-
feine was applied after bathing arterial rings in 0Ca  EGTA
(1 mmol/L) solution during the indicated time. Caffeine-evoked
contraction (B) and RhoA activation (C) in arterial rings bathed in
a 0Ca  EGTA solution (caffeine 10 mmol/L, n3). The vertical
arrow indicates the time (10 minutes after caffeine application) at
which arterial rings were frozen (F) for posterior measurement of
RhoA activity. D, Statistical analysis of the effect of FPL on
RhoA activation at different times during depletion of intracellu-
lar calcium stores (n4). Experimental conditions similar to (A).
E, Representative trace of FPL-evoked contraction (2 minutes,
5.340.44 mN, n16; 10 minutes, 0.20.8 mN, n15; 30 min-
utes, 0.250.2 mN, n15; 60 minutes, 0.10.5, n15). F, Sta-
tistical analysis of RhoA activation in response to FPL
(0.5 mol/L) in arterial rings bathed with 0Ca  EGTA external
solution (n3). Vertical arrows indicate the time at which arterial
rings were frozen (F) for posterior measurement of RhoA activ-
ity. Values are presented as meanSEM. **P0.01.
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Therefore, it is possible that a residual transmembrane Ca2
influx, without effect on the contractile machinery itself,
contributes to refilling of peripherally located SR, in which
membranes of the plasmalemma and the superficial SR come
close together.34 Accumulation of Ca2 in the SR would then
permit subsequent release of enough Ca2 to activate or
sensitize the contractile apparatus. This proposal explains
why both the phasic and tonic components of contraction
depend on extracellular Ca2. The higher sensitivity of the
tonic phase of contraction to nifedipine could be explained
because it is known that this drug has more affinity for the
inactivated state of the Ca2 channels than for channels that
are in the closed or open states.35 Because before stimulation
channels are mainly in the closed state, a higher dose of the
antagonist is required to block the phasic component of the
contraction.
Sustained Depolarization-Evoked Contraction Requires
L-type Ca2 Channel-Dependent Metabotropic
RhoA/ROCK Activation
In accord with previous observations,9,27 we have shown in
immunostained isolated myocytes the redistribution of acti-
vated RhoA and its displacement toward the plasma mem-
brane after high K induced depolarization. In intact arteries,
pharmacological inhibition of ROCK (a downstream effector
of RhoA) selectively inhibited the tonic phase of contraction
without altering the Ca2 signal. Therefore, the data sug-
gested that besides metabotropic Ca2 release, activation of
the RhoA/ROCK pathway is necessary for tonic myocyte
contraction. In reversibly permeabilized arteries, RhoA activ-
ity was found increased in sustained depolarized arteries, and
both contraction and RhoA activation decreased in parallel
after G-protein blockade with GDPS or inhibition of InsP3
Figure 8. Ca2-dependence of the caffeine-evoked and FPL64176 (FPL)-evoked contractions in rabbit basilar arterial rings. A,
Statistical analysis of the caffeine (10 mmol/L, n5) evoked contraction at different times in 0Ca solution. B, Statistical analysis of the
FPL-evoked (0.5 mol/L) RhoA activation at different times in 0Ca solution (n9 for t0; n3 for t60 minutes). C, Representative
trace of the time course of the FPL-evoked contraction (2 minutes, 19.181.12 mN, n17; 10 minutes, 26.731.23 mN, n35; 30 min-
utes, 24.920.72 mN, n16). D, Statistical analysis of the time course of FPL-evoked RhoA activation in arterial rings bathed in nomi-
nally 0 external Ca2 (n3 for 2 and 30 minutes; n8 for 10 minutes). Vertical arrows indicate the time at which arterial rings were fro-
zen (F) for posterior measurement of RhoA activity. Values are presented as meanSEM. E, Model illustrating the multiple roles of
L-type Ca2 channel in the initiation and maintenance of arterial contraction. Membrane depolarization induces opening of voltage-
gated Ca2 channels and a sudden increase of cytosolic [Ca2] because of massive Ca2 influx. The increase of cytosolic [Ca2] acti-
vates the calmodulin-dependent myosin light chain kinase to overcome the activity of myosin light chain phosphatase, thus generating
the phasic component of contractions. During a maintained depolarization, activated Ca2 channels induce a metabotropic cascade
leading to inositol trisphosphate synthesis and Ca2 release from sarcoplasmic reticulum (SR). These events activate the RhoA/Rho-
associated kinase sensitization pathway and myosin light chain phosphatase inhibition, maintaining the contraction. During maintained
depolarizations, a residual Ca2 current might contribute to refilling of SR Ca2 store.
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receptors with heparin. Hence, high K-induced sustained
contraction requires G-protein-mediated RhoA activation and
Ca2 sensitization, a phenomenon that was previously
thought to be restricted only to receptor-mediated forms of
smooth muscle activation.3
Because RhoA/Rho kinase is activated by G-protein–
coupled receptor stimulation,4,5 the apparent high K-
induced activation of RhoA/ROCK could, in fact, be attrib-
utable to activation of a G-protein–coupled receptor with
intrinsic voltage sensitivity rather than to membrane depolar-
ization.36 This possibility was discarded because FPL, a Ca2
channel agonist that can activate Ca2 channels without
affecting membrane potential,14,18 induced arterial contrac-
tion and RhoA activation in a qualitatively similar way to the
changes in the same parameters evoked by KCl. Moreover, in
conditional Cav1.2 knockout mice, the absence of FPL-
induced or depolarization-induced L-type Ca2 channels
activation was paralleled by the lack of RhoA activation and
contraction. In this animal model, contraction induced by
caffeine, which bypassed plasma membrane depolarization,
was unchanged. Similarly, RhoA activation induced by phen-
ylephrine, which is G-protein-mediated, was also unaltered.
Therefore, these data strongly suggest that functional L-type
Ca2 channels are required for the high K- evoked or FPL-
evoked RhoA activation. This novel role for VGCC on Ca2
sensitization in VSM helps explain the KCl-evoked Rho/ROCK
activation profusely described in the literature and whose under-
lying mechanisms were unknown.6–10 Our experimental data
also indicate that InsP3-mediated Ca2 release is necessary for
depolarization-evoked or FPL-evoked RhoA activation, because
it was markedly decreased in arterial rings in which the internal
Ca2 stores had been previously depleted. Interestingly,
caffeine-induced Ca2 release did not induce RhoA activation,
thus suggesting that SR Ca2 release per se, bypassing activation
of Ca2 channels and the downstream metabotropic pathway, is
not sufficient to induced RhoA activation. Therefore, RhoA/
ROCK activation and VSM sensitization requires both Ca2
channel activation and CCICR from SR.
In conclusion, the findings reported here suggest that CCICR
links Ca2 channel activation with RhoA/ROCK stimulation.
They indicate that depolarization-evoked sustained RhoA acti-
vation and myocyte contraction do not depend on the change in
the membrane potential itself or the mere release of Ca2 from
the SR, but they require the simultaneous activation of VGCC
and the downstream stimulation of a metabotropic pathway,
leading to InsP3 synthesis and Ca2 release. An explanatory
summary of the ionotropic and metabotropic functions of VGCC
regulating VSM contraction is given in Figure 8E. Our results
could have a wide functional relevance for the pathogenesis of
vasospasms mediated by vasoactive agents, such as noradrena-
lin, endothelin, or ATP, that can activate VGCC.18,37,38 Because
sustained VSM depolarization and VGCC activation mediate
numerous pathophysiological processes,39–42 the data could also
help to optimize therapeutic treatment for clinical conditions
such as hypertension, angina pectoris, and cardiac arrhythmias,
in which Ca2 channels antagonist are recommended.43
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Novelty and Significance
What Is Known?
● L-type Ca2 channels constitute an important pathway for extracel-
lular Ca2 influx and vascular smooth muscle contraction.
● In the absence of extracellular Ca2, Ca2 channels in vascular
myocytes act as voltage sensors that couple membrane depolar-
ization to G-protein/PLC/InsP3 synthesis and Ca
2 release from
the sarcoplasmic reticulum (SR) (calcium channel-induced cal-
cium release [CCICR]). Both agonist stimulation and membrane
depolarization can evoke Ca2-dependent RhoA/Rho kinase acti-
vation and arterial contraction.
What New Information Does This Article Contribute?
● Depolarization or agonist (ATP)-evoked sustained arterial contraction
requires metabotropic Ca2 release from the SR.
● L-type Ca2 channel activation and metabotropic Ca2channel-induced
Ca2 release play an essential role in depolarization-evoked RhoA/
Rho kinase activation and sustained myocyte contraction.
● Depolarization-evoked sustained RhoA activation does not depend on
the change in membrane potential itself or the mere release of
Ca2 from the SR, but it requires the simultaneous activation of
voltage-gated calcium channels (VGCC) and the downstream
stimulation of a metabotropic pathway, leading to InsP3 synthesis
and Ca2 release.
Although a wide number of investigations have revealed the
important contribution of L-type Ca2 channels and RhoA/Rho
kinase in the pathophysiology of vascular smooth muscle, the
inter-relations between both elements are unknown. We show
for the first time to our knowledge that the depolarization-
evoked sustained contraction in these cells is mediated, at least
in part, by Ca2 channel-induced metabotropic Ca2 release
from the SR. We also demonstrate that sarcolemmal Ca2
channels not only mediate the Ca2 influx that triggers con-
traction but also metabotropically regulate SR Ca2 release and
RhoA/Rho kinase activation responsible for sustained contrac-
tion. These novel findings assign to L-type channels a role in the
regulation of vascular smooth muscle tonus that is much
broader than previously thought and help in the understanding of
the role of Ca2 channels and the RhoA/Rho kinase sensitization
pathway in sustained contraction. Our results could have special
relevance for understanding the pathogenesis of vasospasms
mediated by vasoactive agents that can activate VGCC, such as
noradrenalin, endothelin, or ATP. Because sustained vascular
smooth muscle depolarization and VGCC activation participate in
numerous pathophysiological processes, our data could also
help to optimize therapeutic treatment for clinical conditions
such as hypertension, angina pectoris, and cardiac arrhythmias,
in which Ca2 channels antagonist are recommended.
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MATERIALS AND METHODS 
Confocal microscopy and immunocytochemistry. Isolated cells were placed on coverslips and 
fixed with 4% paraformaldehide in PBS solution for 20 minutes. Subsequently, cells were 
rinsed in this solution and incubated 1 hour in non specific binding solution (PBS, 10% FBS, 1 
mg/mL BSA, 0.1% Triton X-100). We used mouse anti-RhoA antibody (Santa Cruz, USA) and 
rabbit anti-mouse FITC (Sigma-Aldrich, USA) secondary antibody to stain RhoA. Cells were 
incubated for 1 hour at room temperature in mouse anti-RhoA diluted 1:200 in non specific 
binding solution. Cells were rinsed in PBS and incubated for 1 hour in rabbit anti-mouse FITC 
diluted 1:1000 in non specific binding solution. The cell nucleus was marked using propidium 
iodide (1 µg/mL). Finally coverslips were rinsed in PBS and mounted onto slides with DPX. 
Fluorescence was observed with the confocal microscope (Leica, TCS SP2). Excitation was 
done with an Argon-Kripton laser (488 nm) and the emitted fluorescence (500-535 nm) was 
recorded through an oil immersion objective (40x1.25). To measure RhoA cellular distribution, 
six serial z sections were obtained across the width of a stained myocyte, being numbers 3 and 4 
central sections. From each section, two line scans were analyzed. From the corresponding 
surface plots of these line scans, the peak pixel intensities over the outer 15% of each cell width 
were averaged and taken as an estimate of peripheral staining. The peak pixel intensities of the 
remaining central 70% of the stained cell were averaged and taken as an estimate of the 
cytosolic staining. 
RhoA activation assay. Arterials rings that were contracted isometrically were quickly frozen by 
immersion in liquid nitrogen. RhoA activity was determined from these arterial rings using the 
colorimetric G-LISA RhoA activation assay biochemistry kit (Cytoskeleton, USA). Frozen 
tissues were homogenized in lysis buffer. Protein concentration was determined according to the 
manufacturer´s protocol, and tissue extracts were equalized to contain protein concentration of 1 
mg/mL for the assay. Active RhoA was detected using indirect immunodetection followed by a 
colorimetric reaction measured by absorbance at 490 nm. As measurement of RhoA activity by 
G-LISA requires a relatively large amount of tissue, due to the small size of mouse and rat 
basilar arteries we did these experiments either in rabbit basilar artery or in mouse aorta arterial 
rings. Several arterial rings were obtained from a mouse aorta and pooled together for a single 
G-LISA measurement. Each experiment was repeated in at least 5 animals. In the case of rabbit 
basilar arteries, four to six arterial rings from at least two animals, were used in each individual 
G-LISA measurement (non-stimulated, or treated with 70K/FPL). In addition, G-LISA 
measurements in the various experimental conditions were repeated at least three times and 
presented as percentage of control. Each set of data were expressed as mean ± SE of the 
determinations done in duplicate or triplicate.  
Reversible permeabilization. To load rat basilar arteries with GDPβS (10 mmol/L), arteries 
were incubated in the following sequence of solutions kept at 4 ºC  (in mmol/L): 1) 10 EGTA, 
120 KCl, 5 ATP, 2 MgCl2, 20 TES  (pH 6.8, 20 minutes);  2) 120 KCl, 5 ATP, 2 MgCl2, and 20 
TES and 10 mmol/L GDPβS (pH 6.8, 3 hours); and 3) 120 KCl, 5 ATP, 10 MgCl2, and 20 TES 
and 10 mmol/L GDPβS (pH 6.8, 30 minutes). Subsequently, arteries were bathed in a fourth 
solution containing (in mmol/L): 140 NaCl, 5 KCl, 10 MgCl2, 5 glucose, and 2 MOPS (pH 7.1, 
22°C) in which [Ca2+] was gradually increased from 0.01 to 0.1 to 1.8 mmol/L every 15 
minutes. Qualitatively similar protocol was done for reversible permeabilization of rabbit 
arteries, keeping arterial ring in solution 2 for 18 hours. As for unknown reasons rabbit basilar 
arteries did not seem to respond well to the relatively aggressive treatment required for rabbit 
artery permeabilization, we used femoral arteries instead. The method of reversible 
permeabilization was also used to introduce heparin (10 mg/mL).  
Solutions. The composition of Hank’s solution (in mmol/L) was: 125 NaCl, 5.36 KCl, 5 
NaHCO3, 0.34 Na2HPO4, 0.44 KH2PO4, 10 glucose, 1.45 sucrose, and 10 Hepes, pH 7.4. The 
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composition of PBS solution (in mmol/L) was: 137 NaCl, 2.68 KCl, 4.02 Na2HPO4, 1.76 
KH2PO4, pH 7.4. The composition of Kreb´s solution (in mmol/L) was: 119 NaCl, 4.7 KCl, 1.17 
KH2HPO4, 24 NaHCO3, 2.5 CaCl2, 1.17 MgSO4, 5.5 glucose. The 70K+ solution was obtained 
by replacing 70 mmol/L of NaCl with KCl. The 0Ca2+ solution was obtained by substituting 
Mg2+ for Ca2+ and with 1 mmol/L EGTA added (estimated [Ca2+]i < 100 nmol/L). In nominally 
0Ca2+ solution CaCl2 was omitted (estimated [Ca2+]i ≈ 7 μmol/L). [Ca2+] contained in these 
solutions was measured using an electrode (Orion Calcium Electrode, Thermo, Electron Corp., 
USA). To exclude the potential confounding effects on G-proteins of neurotransmitters released 
from nerves innervating the arterial rings we performed the appropriate experimental tests 
(measurement of tension and RhoA activity) using a 70K/FPL solution containing a cocktail of 
receptor antagonists previously used for the same purpose in the literature (Walch, et al. 2000, 
2001; Sakurada, et al. 2003; Yang, et al. 2009; del Valle-Rodríguez, et al. 2006). The 
composition of this cocktail was as follows: ACh receptor antagonist (atropine, 5 µmol/L), 
angiotensin AT1 receptor antagonist (losartan, 1 µmol/L), β-adrenergic receptor blocker 
(propanolol, 10 µmol/L), purinergic P2 receptor blocker (suramin, 25 µmol/L), and 
thromboxane receptor antagonist (AM6809, 1 µmol/L). Arterial ring contraction and RhoA 
activity were not affected by the presence of the indicated drugs (Online Figure I). To record 
whole-cell Ca2+ channel currents the solutions used were as follows (in mmol/L): external (140 
NaCl, 2.7 KCl, 10 BaCl2, 10 HEPES, pH 7.4); internal (100 CsCl, 30 CsF, 2 MgCl2, 4 ATP-Mg, 
10 EGTA, 10 HEPES, pH 7.2). 
 by guest on March 4, 2013http://circres.ahajournals.org/Downloaded from 
CIRCRESAHA/2011/240127/R2       4 
 
 
ADDITIONAL FIGURES 
 
Online Figure I. Effect of a cocktail of different inhibitors of neurotransmitter receptors on 
Ca2+ channel-induced contraction and RhoA activation in basilar artery. A, 70K-induced 
contraction in the presence or absence of the cocktail. B, Quantitative summary of isometric 
contractions induced by 70K solution in the presence of inhibitors of neurotransmitter receptors 
(n=8). C, Effect of the inhibitory cocktail on depolarization-induced RhoA activation. D, FPL-
evoked contraction in the presence or absence of the cocktail. E, Statistical analysis of 
contractions induced by FPL in the presence or absence of the cocktail (n=6).   
 
Online Figure II. Effect of depletion of intracellular Ca2+ stores on Ca2+ channel currents and 
isometric force. A, Effect of CPA (10 µmol/L) on Ca2+ currents recorded from voltage-clamped 
dispersed myocytes using the whole cell configuration of the patch clamp technique. B, Effect 
of CPA on the current/voltage relations of Ca2+ channels (n=4). Arrow indicates that ICa is not 
reduced in the presence of CPA at membrane potentials close to that obtained in cells exposed 
to 70K (≈-20 mV).  C, Effect of thapsigargin (2 µmol/L), an inhibitor of SR Ca2+ pump, on the 
70K-induced contraction. The lack of contraction induced by caffeine (Caf) after treating the 
arterial rings with thapsigargin indicates that intracellular stores were depleted. D, Statistical 
analysis of isometric contractions induced by 70K solution in the presence of CPA (n=6), 
thapsigargin (measured during the first exposure to 70K in the presence of the inhibitor, n=4) 
and ryanodine (n=6) to deplete intracellular Ca2+ stores. Force was measured at 10 minutes after 
stimulus application. E, Cumulative effect of nifedipine (expressed in nmol/L) on the tonic 
component of the 70K-evoked contraction. F, Dose-response curve of the effect of nifedipine on 
the amplitude of the tonic component of the 70K-evoked contraction. Data points relating 
relative isometric force to nifedipine concentration were fitted to a double exponential function 
(Kd = 6.62 nmol/L) (n=6). Values are presented as means ±SEM. *P<0.05. 
 
Online Figure III. Effect of Phospholipase C and ROCK inhibitors on [Ca2+]i and the 
contraction induced by 70K and caffeine. A, Effect of U73122 (1 µmol/L), a phospholipase C 
(PLC) inhibitor, on cytoplasmic calcium increase induced by 70K. B, Statistical analysis of the 
effect of U73122 on intracellular calcium in rat basilar myocytes during both, the phasic and 
tonic components of [Ca2+]i (n=3). C, Arterial ring contractions induced by repeated exposures 
to caffeine (10 mmol/L) in the absence or presence of U73122 (1 µmol/L). Arrows indicate 
caffeine applications. D, Quantitative summary of the action of PLC inhibitor (U73122) on 
caffeine-evoked contractions in rat basilar arterial rings (n=5). The data show that in our 
preparation U73122 had no significant effect on refilling of stores (see, however, Macmillan 
and McCarron, 2010).   E, Effect of the ROCK inhibitor HA 1077 (5 minutes treatment) on the 
70K-evoked contraction. F, Quantitative summary of the inhibition of the relative isometric 
force with two ROCK inhibitors (HA 1077, 2.5 µmol/L, n=6; Y27632, 2.5 µmol/L, n=6), 
relative to the phasic component of the 70K-induced in arterial rings contraction. Values are 
presented as mean±SEM. * P<0.05, ** P<0.01. 
 
Online Figure IV. Effect of Y27632 on the phenylephrine-evoked contraction in mouse 
femoral arterial rings. A, Isometric force developed in response to phenylephrine (1 µmol/L) in 
the presence of the ROCK inhibitor Y27632 (2.5 µmol/L). B, Statistical analysis of the effect of 
Y27632 (2.5 µmol/L, n=6) on phenylephrine-induced contraction in mouse femoral arterial 
rings. Values are presented as mean±SEM. * P<0.05. 
 
Online Figure V. Role of extracellular [Ca2+] and ROCK inhibitors in FPL- and caffeine-
evoked contractions in rat basilar arteries. A and C, Representative recordings of simultaneous 
measurements of [Ca2+] (fluorescence ratio, F340/F380) and force (arterial diameter) in Fura-2 
loaded intact basilar arteries in response to 10 mmol/L caffeine (A) (F340/F380 increased 
0.15±0.02 units, diameter decreased 68.63±9.11 μm, n=8) and 5 µmol/L FPL (C) (F340/F380 
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increased 0.071±0.019 units, diameter decreased 47±19.7 μm, n=4) in external solutions where 
Ca2+ was omitted and 1 mmol/L EGTA was added ([Ca2+] < 100  nmol/L). B, Lack of effect of 
HA 1077 (1 µmol/L) on caffeine-induced arterial ring contraction. D, Effect of Y27632 (2.5 
µmol/L) on the FPL-evoked contraction (41.1±1.3% inhibition at 5 minutes, n=3). E, 
Representative example of three similar experiments of simultaneous measurements of [Ca2+] 
(fluorescence ratio, F340/F380) and force (arterial diameter) in Fura-2 loaded intact basilar arteries 
in response to FPL (5 µmol/L) and HA 1077 (2.5 µmol/L) in an external solution where Ca2+ 
was omitted ([Ca2+] ~7 µmol/L). 
 
Online Figure VI.  Effect of a permeant InsP3–derivative on cytosolic Ca2+ and RhoA activity 
in arterial myocytes. A. Oscillations of cytosolic [Ca2+] induced by Bt-InsP3 AM (5 μmol/L) in 
dispersed rat basilar myocytes. Note that the larger Ca2+ signal induced by high K+ was 
unaffected by application of the drug (representative example of 5 similar experiments).  B and 
C, Quantitative summary of the effect of Bt-InsP3 AM (5 μmol/L) on RhoA activation in intact 
(B, n=3; basilar artery) and in reversibly permeabilized (C, n=3; femoral artery) rabbit arterial 
rings. Bt-InsP3 AM (5 μmol/L) did not induce contraction in any of these arterial preparations 
(data not shown).  
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